Hybrid Conference | 1 Cat. 1 Tuesday, May 5, 2026 | 6:00 p.m. - 7:30 p.m
The management of carotid artery disease is rapidly evolving, with new evidence and advances in therapy reshaping how clinicians approach treatment decisions. Findings from the CREST-2 trial, along with improvements in medical management and revascularization techniques, are redefining the roles of carotid artery stenting and endarterectomy and highlighting the importance of individualized care.
James F. Meschia, M.D., FAAN, FANA, FAHA
Please join us to hear James F. Meschia, M.D., FAHA, Professor of Neurology and Chair Emeritus at the Mayo Clinic, present Modern Approaches to Managing Carotid Disease. This activity will provide a practical, evidence-based update on carotid therapy and equip clinicians with strategies to apply current data, optimize patient selection and enhance clinical decision-making in everyday practice
Learning Objectives
Upon completion of this conference, participants should be better able to: • Evaluate current evidence, including findings from the CREST-2 trial, in the management of asymptomatic carotid artery stenosis • Compare the risks, benefits and indications of intensive medical therapy, carotid artery stenting and carotid endarterectomy • Apply patient-specific factors to guide evidence-based treatment selection for carotid artery disease
